Funding Opportunities by Type
Requests for Applications (RFA)
Find current and recent NCI-supported RFAs that provide funding for various areas of cancer research.
Program Announcements (PA)
Find current and recent PAs that invite requests for funding applications to support specific area of cancer research.
NCI and Trans-NIH Initiatives
Find current and recent NCI and Trans-NIH Research Project Grants (R01 and R21) that provide funding for specific areas of cancer research.
Requests for Proposals for Contracts
Find opportunities for contract funding.
NCI Cleared Concepts
Find concepts for future RFAs and PAs that provide an early alert to applicants of upcoming funding opportunities.
NCI Special Initiatives
Outstanding Investigator Award
The new Outstanding Investigator Award gives investigators the freedom to work on long-term projects with unusual potential in cancer research.
RAS Initiative enlists collaborators from all sectors of the research community to work together to attach mutant RAS-driven cancers.
Provocative Questions Program
Provocative Questions is a NCI initiative that intends to assemble a list of important questions, or problems that are paradoxes in cancer research that will stimulate research communities to use laboratory, clinical, and population sciences in new, effective, and imaginative ways.
NCI Funding Opportunities by Research Topic
Research projects in basic cancer biology are supported and coordinated through the Division of Cancer Biology (DCB).
Biorepositories and Tissue Sample Collection
Development of biospecimen-related policies and practices affecting NCI Biorepositories is coordinated and managed through the Office of Biorepositories and Biospecimen Research (OBBR).
Complementary and Alternative Medicine
Research contributing to the advancement of evidence-based complementary and alternative medicine practice is supported by the Office of Cancer Complementary and Alternative Medicine (OCCAM).
Cancer Health Disparities
Basic cancer research from a health disparities perspective is supported by the Center for Cancer Health Disparities.
Epidemiology and Cancer Control
Research in genetic, epidemiologic, behavioral, social, and surveillance cancer research is supported by the Division of Cancer Control and Population Sciences (DCCPS).
Genomics – sequencing
Research aimed at accelerating our understanding of the molecular basis of cancer through the application of genome analysis technologies and is supported by The Cancer Genome Atlas Program (TCGA).
HIV /AIDS and Cancer
Research on HIV/AIDS pursued throughout the NCI, including programs in AIDS-related cancer are coordinated by the Office of HIV and AIDS Malignancy (OHAM).
Research supporting the application of nanotechnology to all aspects of cancer research is supported by the NCI Alliance for Nanotechnology in Cancer program that managed by the Office of Cancer Nanotechnology Research (OCNR).
Research supporting the establishment of scientific teams and individual scientists from the fields of physics, mathematics, chemistry, and engineering to develop novel approaches for cancer research is managed by the Office of Physical Sciences-Oncology (OPSO).
Research that determines and reduces a person’s risk of developing cancer, as well as research to develop and evaluate cancer screening procedures, is supported by the Division of Cancer Prevention (DCP).
Research supporting the development of technologies and reagents that will advance our understanding of protein biology in cancer is supported by the Office of Cancer Clinical Proteomics (OCCPR).
Small Business and Small Business Technology Transfer
Opportunities to increase small business and private sector participation to develop and commercialize novel technologies to prevent, diagnose, and treat cancer are managed by the Small Business & Small Business Technology Transfer SBIR and STTR programs (SBIR/STTR).
Resources for statisticians are available from StatFund, an online resource that provides information about biostatistical funding opportunities.
Research supporting the development of technologies in clinical, laboratory, and epidemiological research are managed by the Innovative Molecular Analysis Technologies Program (IMAT).
Research supporting the translation of promising research areas into improved diagnostic and therapeutic interventions for cancer patients is supported by the Division of Cancer Treatment and Diagnosis (DCTD).